FOGLIETTA, MYRIAM
FOGLIETTA, MYRIAM
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Distribution of γδ T cells in patients with hematological malignancies
2006-01-01 Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M.
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma
2006-01-01 Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M.
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)
2012-01-01 Marta Coscia; Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Marta Robino; Marina Ruggeri; Daniela Drandi; Paola Omedè; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway.
2014-01-01 P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia.
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2009-01-01 Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M.
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells
2007-01-01 Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia
Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions
2006-01-01 Myriam Foglietta; Sara Mariani; Barbara Castella; Marta Coscia; Laura Godio; Serena Zappia; Mario Boccadoro; Massimo Massaia
Role of PD-1/PD-L1 axis in the immune paresis of bone marrow Vγ9Vδ2 T cells in multiple myeloma
2014-01-01 Castella B; Foglietta M; Sciancalepore P; Rigoni M; Coscia M; Vitale C; Griggio V; Canepari ME; Robino M; Massaia M
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID
2004-01-01 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL)
2012-01-01 Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Daniela Drandi; Marina Ruggeri; Paola Omedé; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia; Marta Coscia
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2017-01-01 Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2017-01-01 Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS
2016-01-01 Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M
The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells
2014-01-01 Rigoni M; Riganti C; Griggio V; Coscia M; Castella B; Foglietta M; Vitale C; Sciancalepore P; Robino M; Boccadoro M; Massaia M
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection
2016-01-01 Vitale C, Griggio V, Todaro M, Riganti C, Salaroglio IC, Salvetti C, Rigoni M, Foglietta M, Castella B, Boccadoro M, Massaia M, Coscia M
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status.
2010-01-01 Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL)
2008-01-01 M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells
2014-01-01 Candida Vitale; Valentina Griggio; Chiara Riganti; Ivana Campia; Marta Robino; Micol Rigoni; Patrizia Sciancalepore; Myriam Foglietta; Barbara Castella; Mario Boccadoro; Massimo Massaia; Marta Coscia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Distribution of γδ T cells in patients with hematological malignancies | 2006 | Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M. | |
| Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma | 2006 | Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M | |
| IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M. | |
| Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) | 2012 | Marta Coscia; Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Marta Robino; Marina Ruggeri; Daniela Drandi; Paola Omedè; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia | |
| Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. | 2014 | P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia. | |
| PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2009 | Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M. | |
| Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells | 2007 | Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia | |
| Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions | 2006 | Myriam Foglietta; Sara Mariani; Barbara Castella; Marta Coscia; Laura Godio; Serena Zappia; Mario Boccadoro; Massimo Massaia | |
| Role of PD-1/PD-L1 axis in the immune paresis of bone marrow Vγ9Vδ2 T cells in multiple myeloma | 2014 | Castella B; Foglietta M; Sciancalepore P; Rigoni M; Coscia M; Vitale C; Griggio V; Canepari ME; Robino M; Massaia M | |
| ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID | 2004 | Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M | |
| Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) | 2012 | Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Daniela Drandi; Marina Ruggeri; Paola Omedé; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia; Marta Coscia | |
| TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2017 | Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M | |
| TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2017 | Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M | |
| TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS | 2016 | Vitale, C; Griggio, V; Todaro, M; Riganti, C; Salaroglio, IC; Salvetti, C; Rigoni, M; Foglietta, M; Castella, B; Boccadoro, M; Massaia, M; Coscia, M | |
| The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells | 2014 | Rigoni M; Riganti C; Griggio V; Coscia M; Castella B; Foglietta M; Vitale C; Sciancalepore P; Robino M; Boccadoro M; Massaia M | |
| The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection | 2016 | Vitale C, Griggio V, Todaro M, Riganti C, Salaroglio IC, Salvetti C, Rigoni M, Foglietta M, Castella B, Boccadoro M, Massaia M, Coscia M | |
| The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. | 2010 | Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia | |
| The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) | 2008 | M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia | |
| The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells | 2014 | Candida Vitale; Valentina Griggio; Chiara Riganti; Ivana Campia; Marta Robino; Micol Rigoni; Patrizia Sciancalepore; Myriam Foglietta; Barbara Castella; Mario Boccadoro; Massimo Massaia; Marta Coscia |